After a brief stint in the top cancer research spot at Gilead, Valeria Fantin jumps over to Sanofi
Just a few months ago, Gilead said it was setting up shop in North Carolina’s Research Triangle, with plans to hire 300 employees in the process. It can now add a new head of oncology research to that list.
After a short stint at Gilead, Valeria Fantin is jumping over to Sanofi as the pharma giant’s newest global head of oncology research. The Dartmouth grad has bounced around a few times over the last decade or so, racking up experience at some of the biggest companies in the industry and adding a handful of blockbusters and first-in-class drugs to her résumé.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
